Vascular Calcification Clinical Trial
Official title:
The Effect of Replacement of Vitamin K Antagonist by Rivaroxaban With or Without Vitamin K2 Supplementation on Vascular Calcifications in Chronic Hemodialysis Patients: A Randomized Controlled Trial
This study examines patients on chronic hemodialysis with non-valvular atrial fibrillation,
who have a CHA2DS2-VASc Score of ≥ 2 and therefore are candidates for or already receive a
vitamin K antagonist.
The first question is whether replacement of the vitamin K antagonist by rivaroxaban is able
to slow progression of vascular calcification. The second question is whether addition of
vitamin K2 to rivaroxaban can further slow down or even halt the progression of vascular
calcification.
The present study targets dialysis patients with non-valvular atrial fibrillation requiring treatment with vitamin K antagonists. It addresses the question whether replacement of the vitamin K antagonist by rivaroxaban is able to slow progression of vascular calcification (VC). The second research question is whether addition of vitamin K2 to rivaroxaban can further beneficially affect the progression of VC. Two non-invasive methods are used to evaluate the impact of interventions on the progression of VC: i.e. coronary artery calcification (CAC) and pulse wave velocity (PWV) measurements. The detection of CAC is predictive for the presence of obstructive coronary artery disease and future coronary events. VC and stiffening of the central elastic-type arteries are independent predictors of cardiovascular morbidity and mortality in hemodialysis patients. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03960437 -
The Effect of Etelcalcetide on CKD-MBD
|
Phase 2 | |
| Recruiting |
NCT04983875 -
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
|
N/A | |
| Completed |
NCT03292029 -
Pilot Medical Evaluation of the T50 Test
|
N/A | |
| Completed |
NCT02561299 -
Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
|
N/A | |
| Completed |
NCT00379899 -
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 4 | |
| Active, not recruiting |
NCT02598635 -
Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis
|
Phase 4 | |
| Completed |
NCT00183001 -
Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification
|
Phase 3 | |
| Completed |
NCT04114695 -
Aortic Calcification and Central Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Not yet recruiting |
NCT03169400 -
Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)
|
N/A | |
| Completed |
NCT03314493 -
Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients
|
Phase 3 | |
| Completed |
NCT03839732 -
Observer Variability in Scoring Abdominal Aortic Calcifications and Vertebral Morphometry
|
||
| Completed |
NCT02542319 -
Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease
|
Phase 2 | |
| Completed |
NCT00481364 -
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
|
Phase 3 | |
| Completed |
NCT00694824 -
Vascular Calcification's Risk Factors in Haemodialysis Patients
|
||
| Recruiting |
NCT01364688 -
Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
|
Phase 2 | |
| Completed |
NCT01675206 -
Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients
|
Phase 3 | |
| Completed |
NCT03937349 -
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
|
||
| Completed |
NCT02719665 -
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
|
N/A | |
| Recruiting |
NCT04753593 -
Use of Discarded Surgery Human Tissue Specimens for Basic Science Research
|
||
| Recruiting |
NCT06035783 -
Calcium Reduction by Orbital Atherectomy in Western Europe
|